Back to results
US 4,902,695 AGranted
Excitatory amino acid receptor antagonists
AssigneeEli Lilly and Company
InventorPaul L. Ornstein
Life of this patent
Estimating the term…
Abstract
The present invention provides novel bicyclic derivatives useful as excitatory amino acid receptor antagonists and in treating a variety of associated nervous system disorders.
Claims20
A compound of the formula ##STR7## and the other of Y and Z is hydrogen;
- each R.sup.3 is independently C.sub.1 -C.sub.16 alkoxy, phenyl-substituted C.sub.1 -C.sub.4 alkoxy, benzyloxy substituted on the phenyl ring with halogen, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.5 alkanoyloxymethyl, or C.sub.1 -C.sub.5 alkanoyloxymethyl substituted on the oxymethyl with C.sub.1 -C.sub.4 alkyl or C.sub.4 -C.sub.7 cycloalkyl;
- each R.sup.4 is independently hydrogen, C.sub.1 -C.sub.16 alkyl, phenyl-substituted C.sub.1 -C.sub.4 alkyl, or phenyl;
- or
- a pharmaceutically acceptable salt thereof.
1 more element
Dependencies are inferred from the claim text.